Bloat in Eld’s Deer During Capture and Chemical Immobilization
The Eld's deer (Rucervus eldii) is a deer species that is indigenous to areas of Southeast Asia. So named because of their discovery by Lt. Percy Eld in the Manipur Valley of India in 1838, there are three recognized subspecies of R. eldii. These include:
- Rucervus eldii eldii (also called the Sangai, it is native to Manipur),
- Rucervus eldii thamin (also called the Thamin, it is native to Burma/Myanmar), and
- Rucervus eldii siamensis, (also called the Siamese Eld’s deer, it is native to Thailand, Annam, and Hainan island).
A large deer that is considered regal in appearance, Eld’s deer are similar in size to white-tailed deer, but differ somewhat in appearance. Their legs are long and thin, and they have slender bodies with a large head and ears. Their rough coats change color with the season. In summer, they are reddish-brown, and dark brown in winter. Stags often have darker coloring than hinds (females) and have a thick mane of long hair around the neck.1
Eld’s deer stags have very large bow- or lyre-shaped antlers which sweep back in a curve of about 40 inches in length. One smaller tine grows toward the front of the head. Antlers are shed every year and reach their largest size during the breeding season.2 Stags grow to about 71 inches in length and weigh from 276 to 386 pounds. They are taller and larger than the hinds, which stand about 60 inches tall.
In their native ranges, Eld’s deer inhabit forested areas, lowland valleys and plains, avoiding dense forests and coastal areas. Today, they occur in a number of protected areas throughout these areas and have been introduced to numerous countries as game animals, including the United States.2
The Eld’s deer’s diet consists largely of grasses, fruits, herbaceous and wetland plants. They are known to graze and to browse opportunistically on cultivated crops such as rice, lentils, maize and peas. On ranches and reserves, Eld’s deer are typically fed a low-protein herbivore diet and alfalfa hay.1,3
Eld’s deer females can begin reproducing at two years of age and typically continue to do so until they are 10 years of age. They begin estrus in the late winter or early spring and have a long period of ovarian activity (225 to 342 days), during which they average 10 to 17 estrous cycles. After they have mated, the females enter anestrus, which usually occurs in the autumn months.2
Chemical Immobilization and Bloat Risks in Eld’s Deer
The management and research of Eld’s deer often requires the use of chemical immobilization. Unfortunately, these animals tend to be prone to a variety of capture‐induced risks while immobilized, including bloat.4 This is a serious condition that is usually fatal if left untreated. In veterinary medicine, it is frequently seen in large dogs and is known as gastric dilatation-volvulus, or GDV, and can occur spontaneously.
Bloat occurs when an animal's stomach fills with gas, food, or fluid and subsequently twists. Stomach distension alone is often referred to as dilatation, or “simple bloat” that can occur spontaneously and can resolve on its own.1 Bloat without twisting (GDV) can be life threatening, but the risk is predicated upon the severity and duration. Bloat is a condition that has been reported in many species of deer; it has been known to occur spontaneously, but is most closely associated with capture and chemical immobilization events.
The Dangers of Bloat in Eld’s Deer
In instances of bloat, it is the twisting and flipping of the stomach that precipitates a life-threatening condition. When the stomach becomes severely distended with gas, fluid or food, it puts pressure on the surrounding organs and decreases blood flow to and from major organs. The twisted stomach is more severe, as it completely obstructs blood supply to these organs and can impact blood flow throughout the whole body, resulting in shock.1
As an animal’s stomach expands, it exerts pressure on the large abdominal arteries and veins. The blood supply is cut off to the stomach; subsequently, toxic products build up and tissues begin to die. Eld’s deer (or any animal experiencing bloat) can go into shock very quickly, and extended periods without treatment increase the risk of further damage and death.1,2
Each species of deer has its own anesthesia recommendations, with intra-species variations of dosages due to the diverse individual responses to anesthetic agents.5,6 These variations are factors in the risk of bloat and other potential complications. Other factors such as stress, venue, individual animal and field conditions must also be taken into account.
Since sedation and anesthesia represent a controlled intoxication of the central nervous system, all sedation/anesthetic events carry risk. Sedative and anesthetic drugs are never completely devoid of toxicity, so their use invariably poses a potential risk, even to the life of completely healthy animals.4
Drug Classes and Immobilization Procedures
Opioids are one of the chief drug classes used in the field immobilization of hoofstock. Unfortunately, opioids can affect thermoregulation, the emetic center (potentially causing nausea and vomiting), and the respiratory system. At a cardiovascular level, bradycardia can occur, as well as arterial hypertension (or hypotension in some cases). Ruminants are thought to be predisposed to gastrointestinal complications (such as bloat) associated with the administration of opioids.4
When performing procedures on chemically-immobilized deer, a sternal recumbency position is vital whenever possible, as bloat can more readily occur with animals in lateral recumbency. Other causes of bloat include the use of immobilization drugs such as the α-2-agonists, which can result in a ruminal atony and subsequently, bloat.4
Alpha-2-agonists and opioids used together have a synergistic effect. These drugs inhibit the norepinephrine release by binding with the α-2-adrenoreceptors. Activity in the Sympathetic Nervous System (SNS) is reduced and it results in a decreased heart rate and blood pressure. They induce muscle relaxation, sedation and analgesia, and reduce the stress response. In higher doses, they can induce vomiting because of the activation of the chemoreceptor trigger zone, hypothermia, miosis and hypoxemia. Through the inhibition of antidiuretic hormones, an animal usually has an increase of urine production and a decrease of gastrointestinal motility which is thought to result in bloat and colic, mainly in herbivores.4,5
Xylazine was the first α-2-agonist to be used in veterinary medicine. Today, it is used in many species, and is easily available and inexpensive. It promotes good muscle relaxation, sedation and a short period of analgesia. It can, however, cause hyper salivation, muscle tremors in some species and GIT motility suppression. The latter can give rise to ruminal atony and bloat.4-6
Resolving Bloat in Eld’s Deer
If an immobilized animal begins to show signs of bloat, all administration of immobilizing drugs must be suspended. The animal should be re-positioned into sternal recumbency with the neck extended and the head with the nose pointing down. Intubation of the animal to relieve gases inside may be done; in some cases, trocharization of the rumen is recommended.4If the veterinarian has high confidence that the bloat is being caused by the anesthetic agents, he or she may employ the available reversal agents to antagonize their effect.4,5
Reversal drugs (e.g., diprenorphine, naltrexone, naloxone) should be given as quickly as possible to avoid the side effects of the immobilizing agents, which may include respiratory depression and cardiovascular issues, among others. Intravenous catheters should be placed and fluid therapy begun, as bloat can cause the heart rate to race at a rate sufficient to cause heart failure.
To stabilize the animal, medication for shock and electrolytes are essential. Premature ventricular contraction (PVC) is often associated with bloat. If this arises, intravenous medications will also be needed to stabilize the heart rhythm. If a disturbed heart rhythm is noted early on, the animal’s prognosis for recovery is generally good.4 In the event of a chemically-immobilized deer’s death, post-mortem gas formation in the alimentary tract should be distinguished from ante-mortem bloating, which itself can be a cause of death.5,6
4Wolfe, B. (2015). Bovidae (except sheep and goats) and antilocapridae. In Miller, R. E., Fowler, M. E. (eds) Zoo and Wild Animal Medicine. (Volume 8). St Louis, Missouri: Elsevier Saunders, 626-644.
5Lance, W. Exotic Hoof Stock Anesthesia and Analgesia: Best Practices. In: Proceedings, NAVC Conference 2008, pp. 1914-15.
6Arnemo, Jon & Kreeger, Terry. (2018). Handbook of Wildlife Chemical Immobilization 5th Ed. Sunquest Publishing, 2007, 432 pages.
About NexGen Pharmaceuticals
NexGen Pharmaceuticals is an industry-leading veterinary compounding pharmacy, offering sterile and non-sterile compounding services nationwide. Unlike other veterinary compounding pharmacies, NexGen focuses on drugs that are difficult to find or are no longer available due to manufacturer discontinuance or have yet to be offered commercially for veterinary applications, but which still serve a critical need for our customers. We also specialize in wildlife pharmaceuticals, including sedatives and their antagonists, offering many unique options to serve a wide array of zoo animal and wildlife immobilization and anesthesia requirements.
Our pharmacists are also encouraged to develop strong working relationships with our veterinarians in order to better care for veterinary patients. Such relationships foster an ever-increasing knowledge base upon which pharmacists and veterinarians can draw, making both significantly more effective in their professional roles.
Disclaimer
The information contained in this blog post is general in nature and is intended for use as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medications shown, nor is the information intended as medical advice or diagnosis for individual health problems or for making an evaluation as to the risks and benefits of using a particular medication. You should consult your veterinarian about diagnosis and treatment of any health problems. Information and statements have not been evaluated by the Food and Drug Administration ("FDA"), nor has the FDA approved the medications to diagnose, cure or prevent disease. Medications compounded by NexGen Pharmaceuticals are prepared at the direction of a veterinarian. NexGen Pharmaceuticals compounded veterinary preparations are not intended for use in food and food-producing animals.
NexGen Pharmaceuticals, LLC does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific dosing, products, procedures, treatments, services, opinions, veterinary care providers or other information that may be contained in this blog post. NEXGEN PHARMACEUTICALS, LLC IS NOT RESPONSIBLE NOR LIABLE FOR ANY ADVICE, COURSE OF TREATMENT, DIAGNOSIS OR ANY OTHER INFORMATION, SERVICES OR PRODUCTS THAT YOU OBTAIN THROUGH THIS BLOG POST.